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study, acidosis induced with acetazola-
mide treatment resulted in the appearance 
of B2 in the apical membrane of   -inter-
calated cells, suggesting that another H   +   -
ATPase or an H   +   -ATPase that includes 
both B1 and B2 can be recruited to the 
plasma membrane when assembly of the 
holoenzyme is stressed. 13 
 Intercalated cells are highly dynamic 
and can rapidly respond to the signals 
induced by systemic acid / base changes to 
reduce or increase their rate of vectoral 
acid secretion. Th e major mechanism uti-
lized for adjusting the transport rate in 
both acute and chronic states is up- or 
downregulation of the H   +   -ATPase and 
anion exchangers (AE1 in   -intercalated 
and pendrin in   -intercalated cells) 
inserted into the apical and basolateral 
membranes. Long-term adaptation uti-
lizes this same response in addition to 
changes in the overall expression level of 
these transporters and, at some yet-to-be-
quantitated rate, the interconversion of 
  - and   -intercalated cells. 
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 In 1961, Sarles  et al. fi rst described an entity 
of sclerosing pancreatitis with hypergam-
maglobulinemia and hypothesized that this 
entity was an autoimmune phenomenon. 1 
Since then, this disease has been recog-
nized as being related to increased IgG4, 
both as elevated levels of IgG4 in patient 
serum and in tissue sections with increased 
IgG4   +   plasma cells. In the past few years, 
the extrapancreatic features of  ‘ autoim-
mune pancreatitis ’ (AIP) have been recog-
nized, 2 thus calling for a new name for the 
disease. Now, IgG4-related systemic disease 
has been described in nearly every organ 
and organ system, fi rst recognized in the 
pancreas, and then recognized in the liver, 
 gallbladder, other gastrointestinal sites 
(sometimes including infl ammatory bowel 
disease), salivary or lacrimal glands, lung, 
breast, retroperitoneum, lymph nodes, 
pituitary gland, prostate, and aorta. 
 Th e entity of IgG4-related systemic dis-
ease, while enjoying increased attention in 
the literature, has been largely unrecognized 
in regular clinical practice, especially when 
it aff ects organs outside of the pancreas. 
This disease is even more likely to be 
un diagnosed in the kidney, when renal 
biopsies of IgG4-related disease are diag-
nosed simply as tubulointerstitial nephritis 
(TIN) without a more specific diagnosis 
indicating the underlying cause of this dis-
ease pattern. As with glomerular diseases, 
which are, for the most part, specifi c and well 
defi ned in terms of histologic, ultrastruc-
tural, and immunophenotypic features, 
pathologists and clinicians should strive 
to identify and describe tubulointerstitial 
diseases in the same manner, with clinico-
pathologic correlation. TIN may be 
 IgG4-related tubulointerstitial 
nephritis 
 Lynn D.  Cornell 1 
 Tubulointerstitial nephritis (TIN) is a disease pattern with heterogeneous 
causes. Recently a specific subtype of autoimmune TIN, IgG4-related 
TIN, has been identified that is part of systemic IgG4-related disease/ 
autoimmune pancreatitis. On biopsy, this TIN shows an IgG4 +  plasma 
cell-rich infiltrate, akin to the pancreatic tissue findings in autoimmune 
pancreatitis, and may show tubulointerstitial immune complex deposits. 
Notably, some cases may be mass-forming. Recognition of this specific 
type of TIN can guide appropriate patient therapy. 
 Kidney International (2010)  78, 951 – 953.  doi: 10.1038/ki.2010.342 
 1 Department of Laboratory Medicine and Pathology, 
Mayo Clinic ,  Rochester ,  Minnesota ,  USA  
 Correspondence: Lynn D. Cornell, Department of 
Laboratory Medicine and Pathology, Mayo Clinic, 
200 1st Street SW, Rochester, Minnesota 55902, 
USA. E-mail:  cornell@alum.mit.edu 
commentar y
952   Kidney International (2010) 78 
immunologically mediated, associated 
with drugs (allergic or toxic), associated 
with infection (either by direct infection 
or in reaction to a distant infection), 
hereditary, or metabolic or may be due to 
other causes ( Figure 1 ). Overlap between 
categories is sometimes seen. TIN may 
also be a primary disease or may be asso-
ciated with systemic disease. Recognition 
of the specifi c type of TIN then guides 
appropriate patient therapy. 
 Saeki  et al. 3 (this issue), in a multicenter 
study, describe the largest histopathologic 
series to date of renal parenchymal 
involvement by IgG4-related disease. 
From a group of 153 patients with sus-
pected IgG4-related systemic disease, 
approximately 20 % had evidence of renal 
parenchymal disease, including radio-
graphic abnormalities, abnormal urinaly-
sis, or renal dysfunction. Th is percentage 
is similar to that seen in radiographic 
studies demonstrating 30 % of patients 
with AIP as having renal parenchymal 
involvement. 4 Th e predominant feature in 
23 patients whose renal tissue was exam-
ined was TIN, with characteristic histo-
logic features of a plasma cell-rich 
infiltrate with a significant number of 
eosinophils in some cases. IgG4 immu-
nostaining revealed at least a moderate 
amount of IgG4   +   plasma cells in all cases. 
Furthermore, all of the 22 patients with a 
measurement had an elevated serum IgG4 
level, and the other patient had an elevated 
serum total IgG level. Nearly all of the 
patients included in the study had some 
form of extrarenal involvement by this 
autoimmune disease, notably 13 of 23 
without a diagnosis of (pancreatic) AIP. 
 Th e study by Saeki  et al. 3 draws atten-
tion to and further defi nes this specifi c 
type of TIN. Th e presence of a plasma cell-
rich TIN in a patient with a renal mass or 
enlarged kidneys on imaging studies, 
hypergammaglobulinemia, hypocomple-
mentemia, or a history of an extrarenal 
inflammatory mass should alert the 
pathologist to consider this entity, and 
perhaps to perform IgG4 immunostain-
ing. Although not specifi cally studied by 
Saeki  et al. , tubular basement membrane 
immune complex deposition is a helpful 
feature to suggest an autoimmune etiology 
of TIN and may show IgG4-dominant 
staining in cases of IgG4-related TIN. 5 
 How useful is IgG4 immunostaining in 
cases of TIN? In the pancreas, a moderate 
to marked increase in IgG4   +   plasma cells 
(usually defi ned as at least 10 cells per 
high-power fi eld in the most dense areas) 
is one of the diagnostic criteria for AIP. 6 
In one study, although such an increase 
was diagnostically helpful when present, 
only 72 % of AIP patients had at least mod-
erately increased IgG4   +   plasma cells in 
pancreatic specimens. 6 Th is fi nding cor-
relates with other studies that show 
elevated serum IgG4 in only about 70 % 
of patients. Elevated serum IgG4 levels 
and tissue IgG4   +   plasma cells tend to 
occur together. 7 Certainly, IgG4 immu-
nostaining is useful in supporting an 
etiologic link between AIP and its extra-
pancreatic involvement in the kidney. 
Th e diagnostic specifi city of IgG4 stain-
ing in the kidney is unknown, however, 
and so the pathologist cannot rely on 
this one test to make the diagnosis. 
 Furthermore, in the study by Saeki 
 et al. , 3 patients were selected for inclusion 
on the basis of having increased IgG4 in 
tissue or in the serum, and so those 
potential patients with  ‘ low-IgG4 ’ AIP-
associated disease were necessarily 
excluded. Extrapolating from the pancre-
atic literature,  ‘ low-IgG4 ’ TIN associated 
with a systemic autoimmune disease 
may aff ect up to 30 % of these TIN cases. 
Defi nition of  ‘ low-IgG4 ’ autoimmune TIN, 
therefore, remains an open question. 
 A few scattered case reports exist of 
glomerular disease in IgG4-related sys-
temic disease, mostly reports of membra-
nous glomerulonephritis (MGN). This 
largest series of IgG4-related TIN includes 
two cases of MGN ( ~ 9 % of the cases), along 
with one case of IgA nephropathy, and 
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 Figure 1  |  Classification of tubulointerstitial nephritis / nephropathy. Tubulointerstitial 
nephritis / nephropathy cases can be placed into different etiologic categories, with the 
approximate relative prevalence on renal biopsy represented here by the size of each bubble. 
Tubulointerstitial nephritis (TIN) associated with systemic IgG4-related disease is an autoimmune 
TIN that usually has tubular basement membrane (TBM) and interstitial immune complex deposits. 
TBM deposits are an unusual feature in the absence of glomerular immune deposits, and their 
presence can help categorize a TIN. Sometimes overlap between etiologic categories exists: for 
example, some cases of BK polyomavirus infection show TBM immune complex deposits that 
stain for IgG and C4d, which may indicate an additional autoimmune reaction; and some cases of 
methicillin-induced TIN have anti-TBM antibodies. NSAID, nonsteroidal anti-inflammatory drug; 
TINU, tubulointerstitial nephritis with uveitis.  
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three cases of other (undefi ned) glomerular 
disease. MGN as a potential etiologic link 
with IgG4-related systemic disease is 
intriguing because idiopathic MGN is also 
an IgG4-dominant disease, such that these 
may have a common pathogenetic link. 
 IgG4 itself is an unusual antibody and 
has some unusual physical characteristics. 
It is the rarest IgG subclass in the circula-
tion of normal individuals. Elevated titers 
of IgG4 are found in conditions of chronic 
antigen exposure; beekeepers, for exam-
ple, show elevated IgG4 directed against 
bee venom, and patients undergoing 
allergen immunotherapy develop 
increased IgG4 titers against the allergen. 
Compared with IgG1, the IgG4  molecule 
has weaker interchain disulfi de bridges, 
so that immunoglobulin half-molecules, 
composed of one heavy chain and one 
light chain, dissociate from each other. 
Once these dissociate, an IgG4 half-mol-
ecule may reassociate with another half-
molecule with specifi city for a diff erent 
antigen. 7,8 When IgG4 encounters anti-
gen, it can only form small, and presum-
ably harmless, immune complexes and 
may block antigen binding by the more 
pathogenic IgG1. IgG4 is also unable to fi x 
complement. In these ways, IgG4 is 
thought to act as an anti-infl ammatory 
molecule that can temper the immune 
response, at least in some circumstances. 
 While IgG4 is an  ‘ anti-inflammatory ’ 
immunoglobulin, it is perplexing that it is 
found to be increased in some disease states, 
most notably IgG4-related systemic disease. 
Th e mechanism of this disease and its asso-
ciation with IgG4 is unclear. IgG4 class 
switching depends on interleukin-4 and/or 
interleukin-13 mainly secreted by T-helper 
2 cells. Th ese are the same cytokines that 
promote an IgE response, although IgG4 
antibody may be present in the absence of 
IgE antibody against a particular antigen. 
Interleukin-10 (IL-10) has an eff ect on IgG4 
versus IgE class switching 9 and may be 
required for IgG4 class-switched B cells to 
diff erentiate into IgG4-secreting plasma 
cells. One may speculate that, in IgG4-
related systemic disease, an initial insult and 
process involving production of anti-
infl ammatory cytokines, including IL-10 
and tumor necrosis factor-  α , along with 
fi brogenic IL-13, drives increased fi brosis, 
induction of IgG4 class-switched B cells, 
and production and massive expansion of 
IgG4-secreting plasma cells. 
 TIN is a disease pattern with heteroge-
neous causes, both immune and nonim-
mune. Th e clinical presentation, laboratory 
results, and biopsy features are all consid-
ered to make a specifi c diagnosis. Th rough 
the work of Saeki  et al. , 3 we now have a 
clearer view of the clinicopathologic fea-
tures of a specifi c type of TIN that is part 
of systemic IgG4-related disease, which in 
turn will aid pathologists and clinicians in 
recognizing and offering appropriate 
treatment for this disease. 
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 Within the past few years, it has become 
apparent that fi broblastic growth factor 23 
(FGF23), a bone-derived phosphaturic 
hormone, plays a central role in the physio-
logical regulation of mineral and vitamin D 
metabolism. FGF23 induces urinary 
phosphate excretion by supp ress ing the 
expression of the sodium-phosphate 
cotransporter. FGF23 also suppresses the 
synthesis of 1,25-dihydroxyvitamin D 
[1,25(OH) 2 D] via inhibition of 1  -
hydroxylase and stimulation of 24-
hydroxylase. 1 Th ese eff ects are dependent 
on the presence of Klotho, which  converts 
 Parathyroid resistance to FGF23 in 
kidney transplant recipients: back 
to the past or ahead to the future ? 
 Hirotaka  Komaba 1 ,  Masahiro  Koizumi 1 and  Masafumi  Fukagawa 1 
 Fibroblast growth factor 23 (FGF23) modulates the metabolism of 
minerals and vitamin D. In chronic kidney disease (CKD), this process is 
disturbed owing to decreased parathyroid expression of FGF23 ’ s 
receptor complex Klotho-FGF receptor 1. In this issue, Krajisnik and 
colleagues demonstrate that similar alterations occur in parathyroid 
glands from kidney transplant recipients in association with a decline in 
allograft function. Is it possible that these data can be extrapolated to 
general early-stage CKD patients? 
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